gainsfueluk.com
No products in the cart.
Return To Shopgainsfueluk.com
No products in the cart.
Return To Shop€52.00
ABILIFY 10 mg Bristol – Myers Squibb is a well-established antipsychotic medication primarily used for the treatment of schizophrenia and bipolar disorder. This medication contains aripiprazole as its active ingredient, functioning as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors. It is designed to help stabilize mood and alleviate the symptoms associated with these mental health conditions, making it a crucial component in mental health management. With a half-life of approximately 75 hours, ABILIFY allows for flexible dosing schedules which cater to a patient’s lifestyle and needs.
Choosing an atypical antipsychotic comes with several benefits that can significantly enhance the quality of life for individuals suffering from mental health disorders. ABILIFY, specifically, offers unique advantages that set it apart from traditional antipsychotic medications. Here are some key benefits:
These advantages not only make ABILIFY a preferred choice for many healthcare providers but also empower patients to manage their conditions effectively.
When considering a long-term treatment plan, it’s crucial to evaluate the sustained benefits of ABILIFY 10 mg Bristol – Myers Squibb. This medication has been found to promote consistent therapeutic outcomes, including reduced symptoms of schizophrenia and bipolar disorder. Regular monitoring of blood glucose and lipid profiles is recommended, although monitoring blood levels is not typically necessary. By maintaining holistic health checks, patients can enjoy the lasting effects of the medication while minimising potential risks. Furthermore, the side effects associated with ABILIFY, such as anxiety, insomnia, and nausea, are generally manageable. With proper medical guidance, most individuals can find a treatment balance without significant disruptions to their lifestyle.
In conclusion, ABILIFY 10 mg Bristol – Myers Squibb stands out as a trusted option for those seeking effective management of their mental health. Its unique formulation and benefits ensure that users can lead a more balanced life while effectively managing their symptoms.
| Raw Material | Aripiprazol |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Monitoring blood levels is not typically required, but lipid profiles, blood glucose, and weight should be monitored |
| Also known as | OPC-14597, OPC-31 |
| Blood pressure | Can cause orthostatic hypotension |
| Trade name | Abilify, Aripiprex |
| Storage conditions | Store at room temperature, 15-30В°C (59-86В°F) |
| Chemical name | 7-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one |
| Formula | C23H27Cl2N3O2 |
| Substance class | Atypical antipsychotic |
| Main action | Dopamine D2 and serotonin 5-HT1A receptor partial agonist |
| Half-life | Approximately 75 hours |
| Dosage (medical) | Typically starts at 10-15 mg once daily for schizophrenia, 2-15 mg once daily for bipolar disorder |
| Dosage (sports) | Not applicable |
| Effects | Antipsychotic, mood stabilization, reducing symptoms of schizophrenia and bipolar disorder |
| Side effects | Anxiety, insomnia, nausea, vomiting, blurred vision, somnolence, restlessness, tremor |
| Use in sports | None |
| Manufacturer | Bristol – Myers Squibb |
| Packing | 28 tabs (10 mg/tab) |
Reviews
There are no reviews yet.